Multicenter study of weekly trastuzumab, paclitaxel and carboplatin followed by a week of rest every 28 days in patients with HER2+ metastatic breast cancer – incidence of central nervous system metastases

✍ Scribed by J. Salvador; M. Ruiz-Borrego; J. Bayo-Calero; M. Lomas-Garrido; A. Moreno-Vega; R. Bernabé; M. Valero; D. Vicente-Baz; J. Fuentes; A. López-Ladrón

• Book ID: 119598218
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 73 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70726-2